PCSK9 and inflammatory bowel disease: It has been suggested that tumor necrosis factor-α upregulates PCSK9 mRNA and protein synthesis, determining its circulating levels, as previously demonstrated by Ruscica et al.21 Various studies investigated the clinical value of PCSK9 in different conditions, but data in IBD patients are lacking.